Roche presents early-stage results for latest amyloid-based Alzheimer's attempt

Roche revealed early-stage data for a new Alzheimer’s program on Wednesday as it seeks to jump back into a field littered with failures. In a 60-patient trial testing four different doses of trontinemab, researchers from ...